ASSERTIO HOLDINGS INC (ASRT)
US04546C2052 - Common Stock
ASSERTIO HOLDINGS INC
NASDAQ:ASRT (11/15/2024, 8:00:00 PM)
After market: 0.8317 +0.02 (+2.5%)0.8114
-0.03 (-3.62%)
Company Profile
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The company is headquartered in Lake Forest, Illinois and currently employs 53 full-time employees. The firm has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).
Company Info
ASSERTIO HOLDINGS INC
100 S. Saunders Road, Suite 300
Lake Forest ILLINOIS 60045
P: 12244197106
CEO: Daniel A. Peisert
Employees: 53
Website: https://www.assertiotx.com/
ASRT News
6 days ago - ChartmillGet insights into the top gainers and losers of Monday's after-hours session.As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
6 days ago - Assertio Holdings, Inc.Assertio Reports Third Quarter 2024 Financial ResultsThird Quarter Total Net Product Sales of $28.7 Million Rolvedon Net Product Sales of $15.0 Million Cash and Short-Term Investments of $88.6 Million...
7 days ago - Assertio Holdings, Inc.Assertio Provides Response to Letter from Short-sellerClaims about Rolvedon and Assertio’s Accounting Practices are False and Baseless Short-seller’s Press Release is Another Improper Attempt to Enrich...
a month ago - Assertio Holdings, Inc.Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with...
a month ago - Assertio Holdings, Inc.Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)LAKE FOREST, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with...
3 months ago - Assertio Holdings, Inc.Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024LAKE FOREST, Ill., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with...
ASRT Twits
Here you can normally see the latest stock twits on ASRT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
